Cell Transfer Therapy for Cancer: Lessons from Sequential Treatments of a Patient With Metastatic Melanoma

Eitemau Tebyg

• Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen
  gan: Rosenberg, Steven A., et al.
  Cyhoeddwyd: (2003)
• A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma
  gan: Dudley, Mark E., et al.
  Cyhoeddwyd: (2002)
• Recombinant Fowlpox Viruses Encoding the Anchor-modified gp 100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma
  gan: Rosenberg, Steven A., et al.
  Cyhoeddwyd: (2003)
• Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
  gan: Dudley, Mark E., et al.
  Cyhoeddwyd: (2005)
• Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens
  gan: Rosenberg, Steven A., et al.
  Cyhoeddwyd: (1998)